JPMorgan downgrades Stellantis stock rating on production timeline
JPMorgan has downgraded Stellantis citing concerns over production timelines, adding institutional pressure to a name already reporting a -14.5% net margin and -$7.75 diluted EPS. The downgrade reinforces the bear case that STLA's restructuring is taking longer than expected, but the stock may already price in significant pain.
JPMorgan downgraded Stellantis (STLA) on production timeline concerns, a move that adds sell-side weight to an already troubled fundamental picture. The automaker reported a -14.5% net margin and a diluted EPS of -$7.75 on revenue of $153.5B (down 2.1% YoY) for FY2025 — a rare combination of scale and deep unprofitability that signals ongoing restructuring friction.
The downgrade matters because JPMorgan's institutional influence can accelerate fund redemptions and index-weight reviews for a stock already under pressure. Stellantis has been navigating a CEO transition, inventory glut in North America, and weak Jeep/Ram demand — a cocktail that is now being flagged formally by a top-tier bank.
The second-order question is whether the downgrade is late-cycle. STLA has already sold off substantially from its highs, and a negative EPS print is well-known to the market. Bears argue production timelines slipping further will delay any margin recovery and that the negative EPS means no dividend support. Bulls counter that at deeply distressed valuations, the stock is pricing in a sustained loss cycle that may not materialize if new management executes on cost cuts.
Key things to watch: any production guidance update from management, whether other sell-side firms follow JPMorgan's lead with further downgrades, and whether insider buying emerges at current depressed levels as a contrarian signal. Until the production timeline clarifies, the fundamental backdrop remains firmly negative.
STLA faces a JPMorgan downgrade on top of a -14.5% net margin and negative EPS — the question is whether the selloff is already priced in or if production timeline slippage opens another leg lower.
JPMorgan's downgrade on production timelines compounds an already deeply negative fundamental print — -$7.75 diluted EPS and -14.5% net margins on declining revenue. When a bulge-bracket firm downgrades citing operational (not macro) concerns, it typically signals further consensus downgrades ahead, which can create a sustained drift lower. The lack of EPS support removes any dividend floor that might otherwise attract value buyers.
STLA has already de-rated sharply; if new management pre-announces a credible restructuring plan or production guidance improves, a short squeeze on an oversold, heavily shorted name could inflict quick losses.
CoverageSource: Investing.com · Published here THU, JUL 9 · 3:24 AM ET · the only report in this recordHow this is decided →
Earlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.
No later reports linked yet.
Follow this story to find new evidence in your Following desk.
Price context does not establish that the story caused the move.
At negative EPS and deeply distressed margins, STLA's valuation may already reflect a worst-case scenario, and any credible production ramp or cost-cut announcement from new leadership could trigger a sharp re-rating given the low base.
With JPMorgan flagging production timeline slippage, a -14.5% net margin, and -$7.75 EPS on shrinking revenue, there is no near-term earnings catalyst to reverse sentiment, and further sell-side downgrades could accelerate institutional outflows.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →